Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PARP”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT04503265
What this trial is testing

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant NeoplasmBreast CancerOvarian Cancer+3 more
AtlasMedx, Incorporated 122
Testing effectiveness (Phase 2)Study completedNCT00753545
What this trial is testing

Assessment of Efficacy of AZD2281 in Platinum Sensitive Relapsed Serous Ovarian Cancer

Who this might be right for
Ovarian Cancer
AstraZeneca 265
Testing effectiveness (Phase 2)Active Not RecruitingNCT05327010
What this trial is testing

Testing the Combination of the Anti-cancer Drugs ZEN003694 (ZEN-3694) and Talazoparib in Patients With Advanced Solid Tumors, The ComBET Trial

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmUnresectable Malignant Solid Neoplasm
National Cancer Institute (NCI) 88
Large-scale testing (Phase 3)Looking for participantsNCT03150576
What this trial is testing

Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer

Who this might be right for
Breast Cancer
Cambridge University Hospitals NHS Foundation Trust 780
Testing effectiveness (Phase 2)Looking for participantsNCT05568550
What this trial is testing

Pembro With Radiation With or Without Olaparib

Who this might be right for
Prostate Cancer
Zin W Myint 64
Testing effectiveness (Phase 2)Ended earlyNCT03572478
What this trial is testing

Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer

Who this might be right for
Prostate CancerEndometrial Cancer
University of Chicago 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT02571725
What this trial is testing

PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Neoplasms
New Mexico Cancer Research Alliance 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04644068
What this trial is testing

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies

Who this might be right for
Ovarian CancerBreast CancerPancreatic Cancer+10 more
AstraZeneca 702
Testing effectiveness (Phase 2)Looking for participantsNCT05551208
What this trial is testing

Fluzoparib Combined With Bevacizumab in PSROC Previously Treated With PARPi

Who this might be right for
Ovarian Cancer
Chongqing University Cancer Hospital 42
Early research (Phase 1)Study completedNCT05002868
What this trial is testing

Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors

Who this might be right for
Solid TumorExtensive-stage Small-cell Lung CancerLocally Advanced Breast Cancer+4 more
Rhizen Pharmaceuticals SA 23
Testing effectiveness (Phase 2)Study completedNCT00271765
What this trial is testing

INO-1001, an Intravenous PARP (Poly [ADP Ribose] Polymerase) Inhibitor in Acute Heart Attack Patients Undergoing Primary Percutaneous Coronary Intervention

Who this might be right for
Acute Myocardial Infarction
Inotek Pharmaceuticals Corporation 40
Testing effectiveness (Phase 2)WithdrawnNCT01244009
What this trial is testing

MK-4827 for the Treatment of Mantle Cell Lymphoma (MK-4827-002)

Who this might be right for
LymphomaMantle-Cell
Tesaro, Inc.
Testing effectiveness (Phase 2)Active Not RecruitingNCT05366166
What this trial is testing

Pembrolizumab Plus Olaparib in LA-HNSCC

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
UNC Lineberger Comprehensive Cancer Center 45
Testing effectiveness (Phase 2)Ended earlyNCT01311713
What this trial is testing

Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Participants With Solid Tumors

Who this might be right for
Solid Tumors
Teva Branded Pharmaceutical Products R&D, Inc. 45
Large-scale testing (Phase 3)Active Not RecruitingNCT04821622
What this trial is testing

Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC

Who this might be right for
Prostate Cancer
Pfizer 599
Testing effectiveness (Phase 2)UnknownNCT04824937
What this trial is testing

Telaglenastat + Talazoparib In Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Massachusetts General Hospital 30
Early research (Phase 1)Study completedNCT01237067
What this trial is testing

Olaparib in Combination With Carboplatin for Refractory or Recurrent Women s Cancers

Who this might be right for
Ovarian CancerBreast CancerPrimary Peritoneal Cancer+2 more
National Cancer Institute (NCI) 77
Large-scale testing (Phase 3)Active Not RecruitingNCT06612814
What this trial is testing

PARP Inhibitor With CDK4/ 6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer

Who this might be right for
Breast Cancer Metastatic
Zhimin Shao 307
Testing effectiveness (Phase 2)Ended earlyNCT03891576
What this trial is testing

Newton Study (NEW Dosing MainTenance Therapy Ovarian CaNcer)

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Mario Negri Institute for Pharmacological Research 83
Not applicableNot Yet RecruitingNCT07269574
What this trial is testing

Impact of Dietary Patterns on Prognosis of Ovarian Cancer Patients During PARPi Maintenance

Who this might be right for
Ovarian CancerFallopian Tube CancersPrimary Peritoneal Carcinoma+1 more
Tongji Hospital 600
Next Page